Michael Scolaro

Michael Scolaro

Sep 18, 2017

Group 6 Copy 63
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Developing a new treatment for Ebola Virus Disease

    Ebola is now a threat of global significance. Fatalities are a consequence of the human body's overreactive...

    Viral Causes of Lung Cancer

    We have special access to blood specimens collected from more than 9,000 cancer free people. These individuals...

    Affordable 3D-Printed Neural Devices for Spinal Cord Regeneration

    Medical treatments for spinal cord injuries are expensive and difficult to test. I want to try to develop a...

    Backer Badge Funded